Biogen and Japanese drugmaker Eisai created a surge in hope for an experimental Alzheimer’s drug called BAN2401, after the companies announced positive results in a late-stage trial. That hope ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results